Abnormal Papanicolaou Test: Results and Risk Factors Among Women of Uttarakhand
October - December 2017 | Vol 3 | Issue 4 | Page : 1-4
Manju Lal1, Rupali Sharma2*, Priyanka Goyal3,
1Associate Professor, 3Senior Resident, 4MS Scholar,
Department of Obstetrics and Gynecology, Himalayan Institute of Medical Sciences,
Jolly Grant, Dehradun, Uttarakhand, India. 2Associate Professor, Department
of Obstetrics & Gynecology, G.S. Medical College & Hospital, Pilkhuwa, District-Hapur,
Uttar Pradesh, India.
How to cite this article: : Lal M, Sharma R, Goyal P, Shamim S.
Abnormal Papanicolaou Test: Results and Risk Factors Among Women of Uttarakhand.
Int Arch BioMed Clin Res. 2017;3(4):1-4.
Background: Cervical cancer is a significant health issue worldwide. About 493 million
new cases of cervical cancer are diagnosed each year. About 274 thousand women die
from this disease annually and 83% of these cases are in developing countries. The
aim of this study was to determine the frequency of abnormal cervical cytology among
women attending Gynaecology OPD and to assess the presence of associated risk factors.
Methods: This hospital based cross-sectional study was conducted using a questionnaire
involving women attending Gynaecology OPD of HIMS, Dehradun from January to December
2016. All pap smears cytological examination was conducted using Bethesda system
of classification. Results: 248 (11.6%) women had abnormal cytological findings
with a mean age of 36.84 years. Duration of marriage was found be significantly
longer among those with abnormal Pap smear (18.34 years verses 15.72 years (p<0.05).
Conclusions: Early marriage, increasing parity and longer duration of marriage are
strongly associated with abnormal Pap smear results.
Keywords: Abnormal PAP smear, Cervical cancer, Premalignant
- Mehmetoglu HC et al. Pap smear screening in the primary health care setting: A study
from Turkey. North Am J Med Sci. 2010;2: 467.
- Khorasanizadeh F et al. (2013). Epidemiology of cervical cancer and human papilloma
virus infection among Iranian women-Analyses of national data and systematic review
of the literature. Gynecologic Oncol.2013; 128: 277-8.
- Ncube B et al. Factors associated with the uptake of cervical cancer screening among
women in Portland, Jamaica. N Am J Med Sci. 2015;7: 104-13.
- Aggarwal P. Cervical cancer: Can it be prevented? World J ClinOncol. 2014;5: 775-80.
- McGraw SL, Ferrante JM. Update on prevention and screening of cervical cancer. World
J Clin Oncol. 2014; 5: 744-52.
- Ferlay Jet al. Cancer Incidence and Mortality Worldwide: Sources, Methods and Major
Patterns in GLOBOCAN 2012. International Journal of Cancer. 2015;136: 359-86.
- Goodman, A. HPV Testing as a Screen for Cervical Cancer. British Medical Journal.
- Rodriguez ACet al. Longitudinal Study of Human Papilloma Virus Persistence and Cervical
Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection. Journal
of National Cancer Institute. 2010;102: 315-24.
- Edelstein Z Ret al. Age of Diagnosis of Squamous Cell Cervical Carcinoma and Early
Sexual Experience. Cancer Epidemiology Biomarkers and Prevention. 2010;18: 1070-6.
- Kjaer S et al. Different Risk Factor Patterns for High-Grade and Low-Grade Intraepithelial
Lesions on the Cervix among HPV-Positive and HPV Negative Young Women. International
Journal of Cancer. 1998;76: 613-19.
- Arbyn M et al. Pooled analysis of the accuracy of five cervical cancer screening
tests assessed in eleven studies in Africa and India. Int J Cancer. 2008;123(1):153-60.
- Rosai J. Rosai and Ackermani surgical pathology. 9th ed. St. Louis: CV Mosby;2004.
- Scott JR, Gibbs RS, Karlan BY, Haney AF. Danforth’s Obstetrics and Gynecology. 9th
ed. Philadilphia; Lippincott Williams and Wilkins: 2003.
- Patro BK, Nongkynrih B. Review of screening and preventive strategies for cervical
cancer in India. Indian J Public Health. 2007;51:216-21.
- Solomon Det al. The 2001 Bethesda System: Terminology for Reporting Results of Cervical
Cytology. Journal of American Medical Association. 2002;287: 2114-9.
- Beral V, Hermon C, Munoz N, Devesa S. Cervical cancer. Cancer Surveys. 1994; 19/20:
- Varghese C et al. Risk factors for cervical dysplasia in Kerala, India. Bulletin
of the World Health Organization. 1999; 77: 3.
- Chichareon S et al. Risk Factors for Cervical Cancer in Thailand: a Case–Control
Study. J Natl Cancer Inst. 1998;90:50–7.
- Saslow D et al. American Cancer Society Guideline for the Early Detection of Cervical
Neoplasia and Cancer. CA Cancer J Clin. 2002;52: 342-62.
- Winkelstein W. Smoking and cervical cancer: current status - a review. Am J Epidemiol.
- Castellsague X, Muñoz N. Cofactors in human papillomavirus carcinogenesis-role of
parity, oral contraceptives, and tobacco smoking. J Natl Cancer InstMonogr.2003;
- Tay SK, Tay KJ. Passive cigarette smoking is a risk factor in cervical neoplasia.
Gynecol On-col. 2004;93: 116–20.
- Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papilloma virus
and cervical cancer. Asian Pac J Cancer Prev. 2010;11:53-78.